Skip to main content

Who Takes Part in Clinical Drug Trials?

Abstract

Drawing on statistical data, this chapter illustrates the considerable variations in the backgrounds of healthy volunteers. I present the demographic profiles of healthy volunteers and introduce the relationship between income, financial rewards, and financial security. I illustrate how healthy volunteering in the UK may not be delineated purely as the preserve of marginalised and unemployed individuals . Rather, based on the sample used in the research informing this book, it appears that healthy volunteers in the UK are mostly employed in full-time and relatively well-paid jobs . I argue that healthy volunteer involvement should be seen in the context of rising costs of living and that this makes taking part in clinical drug trials a worthwhile option for some people.

Keywords

  • Clinical drug trials
  • Healthy volunteers
  • Demographics
  • Volunteering
  • Income

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-319-59214-5_4
  • Chapter length: 12 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   54.99
Price excludes VAT (USA)
  • ISBN: 978-3-319-59214-5
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   69.99
Price excludes VAT (USA)
Hardcover Book
USD   69.99
Price excludes VAT (USA)

References

  • Abadie, R. (2010). The professional guinea pig: Big pharma and the risky world of human subjects. London: Duke University Press.

    CrossRef  Google Scholar 

  • Boyce, M., et al. (2012). TOPS: An internet-based system to prevent healthy subjects from over-volunteering for clinical drug trials. European Journal of Clinical Pharmacology, 68(7), 1019–1024.

    CrossRef  Google Scholar 

  • Byrnes, J. P., et al. (1999). Gender differences in risk taking: A meta-analysis. Psychological Bulletin, 125(3), 367.

    CrossRef  Google Scholar 

  • Elliott, C. (2008). Guinea-pigging: Healthy human subjects for drug safety trials are in demand. But is it a living?. New Yorker (New York, NY: 1925), 36–41.

    Google Scholar 

  • Epstein, S. (2008). The rise of recruitmentology: Clinical research, racial knowledge, and the politics of inclusion and difference. Social Studies of Science, 38(5), 801–832.

    CrossRef  Google Scholar 

  • Fisher, J. A. (2007). Coming soon to a physician near you: Medical neoliberalism and pharmaceutical clinical drug trials. Harvard Health Policy Review: A Student Publication of the Harvard Interfaculty Initiative in Health Policy, 8(1), 61.

    Google Scholar 

  • Frank, G. (2004). Current challenges in clinical trial patient recruitment and enrollment. SoCRA Source, 30. Available at: http://www.socra.org/pdf/200402_Current_Challenges_Recruitment_Enrollment.pdf.

  • Gardner, M., & Steinberg, L. (2005). Peer influence on risk taking, risk preference, and risky decision making in adolescence and adulthood: An experimental study. Developmental Psychology, 41(4), 625.

    CrossRef  Google Scholar 

  • Monahan, T., & Fisher, J. A. (2015). “I’m still a Hustler”: Creative and entrepreneurial responses to precarity by participants in phase I clinical drug trials. Economy and Society, 44, 545–566.

    CrossRef  Google Scholar 

  • Padley, M., & Hirsch, D. (2014). Households below a minimum income standard: 2008/2009 to 2011/2012. Joseph Rowntree Foundation. Available at: http://www.jrf.org.uk/publications/households-below-minimum-income-standard.

  • Sax, L. J., Gilmartin, S. K., & Bryant, A. N. (2003). Assessing response rates and nonresponse bias in web and paper surveys. Research in Higher Education, 44(4), 409–432.

    CrossRef  Google Scholar 

  • Tishler, C. L., & Bartholomae, S. (2002). The recruitment of normal healthy volunteers: A review of the literature on the use of financial incentives. The Journal of Clinical Pharmacology, 42(4), 365–375.

    CrossRef  Google Scholar 

  • Tishler, C. L., & Bartholomae, S. (2003). Repeat participation among normal healthy research volunteers: Professional guinea pigs in clinical trials? Perspectives in Biology and Medicine, 46(4), 508–520.

    CrossRef  Google Scholar 

  • Tolich, M. (2010). What if Institutional Review Boards (IRBs) treated healthy volunteers in clinical trials as their clients?. Australasian Medical Journal, 3(12).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shadreck Mwale .

Rights and permissions

Reprints and Permissions

Copyright information

© 2017 The Author(s)

About this chapter

Cite this chapter

Mwale, S. (2017). Who Takes Part in Clinical Drug Trials?. In: Healthy Volunteers in Commercial Clinical Drug Trials. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-319-59214-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59214-5_4

  • Published:

  • Publisher Name: Palgrave Macmillan, Cham

  • Print ISBN: 978-3-319-59213-8

  • Online ISBN: 978-3-319-59214-5

  • eBook Packages: Social SciencesSocial Sciences (R0)